TY - JOUR T1 - Projecting contact matrices in 177 geographical regions: an update and comparison with empirical data for the COVID-19 era JF - medRxiv DO - 10.1101/2020.07.22.20159772 SP - 2020.07.22.20159772 AU - Kiesha Prem AU - Kevin van Zandvoort AU - Petra Klepac AU - Rosalind M Eggo AU - Nicholas G Davies AU - Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group AU - Alex R Cook AU - Mark Jit Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/28/2020.07.22.20159772.abstract N2 - Mathematical models have played a key role in understanding the spread of directly-transmissible infectious diseases such as Coronavirus Disease 2019 (COVID-19), as well as the effectiveness of public health responses. As the risk of contracting directly-transmitted infections depends on who interacts with whom, mathematical models often use contact matrices to characterise the spread of infectious pathogens. These contact matrices are usually generated from diary-based contact surveys. However, the majority of places in the world do not have representative empirical contact studies, so synthetic contact matrices have been constructed using more widely available setting-specific survey data on household, school, classroom, and workplace composition combined with empirical data on contact patterns in Europe. In 2017, the largest set of synthetic contact matrices to date were published for 152 geographical locations. In this study, we update these matrices with the most recent data and extend our analysis to 177 geographical locations. Due to the observed geographic differences within countries, we also quantify contact patterns in rural and urban settings where data is available. Further, we compare both the 2017 and 2020 synthetic matrices to out-of-sample empirically-constructed contact matrices, and explore the effects of using both the empirical and synthetic contact matrices when modelling physical distancing interventions for the COVID-19 pandemic. We found that the synthetic contact matrices reproduce the main traits of the contact patterns in the empirically-constructed contact matrices. Models parameterised with the empirical and synthetic matrices generated similar findings with few differences observed in age groups where the empirical matrices have missing or aggregated age groups. This finding means that synthetic contact matrices may be used in modelling outbreaks in settings for which empirical studies have yet to be conducted.Author summary The risk of contracting a directly transmitted infectious disease such as the Coronavirus Disease 2019 (COVID-19) depends on who interacts with whom. Such person-to-person interactions vary by age and locations—e.g., at home, at work, at school, or in the community—due to the different social structures. These social structures, and thus contact patterns, vary across and within countries. Although social contact patterns can be measured using contact surveys, the majority of countries around the world, particularly low- and middle-income countries, lack nationally representative contact surveys. A simple way to present contact data is to use matrices where the elements represent the rate of contact between subgroups such as age groups represented by the columns and rows. In 2017, we generated age- and location-specific synthetic contact matrices for 152 geographical regions by adapting contact pattern data from eight European countries using country-specific data on household size, school and workplace composition. We have now updated these matrices with the most recent data (Demographic Household Surveys, World Bank, UN Population Division) extending the coverage to 177 geographical locations, covering 97.2% of the world’s population. We also quantified contact patterns in rural and urban settings. When compared to out-of-sample empirically-measured contact patterns, we found that the synthetic matrices reproduce the main features of these contact patterns.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe following funding sources are acknowledged as providing funding for the named authors. KP, PK and MJ were partly funded by the Bill & Melinda Gates Foundation (INV-003174). MJ and NGD were partly funded by the National Institute for Health Research (NIHR, NIHR200929) MJ was partly funded by NIHR using UK aid from the UK Government to support global health research (16/137/109). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. KvZ was partly funded by DfID/Wellcome Trust (Epidemic Preparedness Coronavirus research programme 221303/Z/20/Z) and DfID/Wellcome Trust/NIHR (Elrha R2HC/UK DFID/Wellcome Trust/NIHR). KP, PK and MJ were partly funded by the European Union Horizon 2020 research and innovation programme - project EpiPose (101003688). RME was partly funded by HDR UK (MR/S003975/1) and UK MRC (MC_PC 19065). PK was partly funded by the Royal Society (RP\EA\180004). ARC was partly funded by the Singapore National Medical Research Council (COVID19RF-004, NMRC/CG/C026/2017_NUHS). The following funding sources are acknowledged as providing funding for the working group authors. Alan Turing Institute (AE). BBSRC LIDP (BB/M009513/1: DS). This research was partly funded by the Bill & Melinda Gates Foundation (INV-001754: MQ, INV-003174: YL, NTD Modelling Consortium OPP1184344: CABP, GM, OPP1180644: SRP, OPP1183986: ESN, OPP1191821: KO R, MA). DFID/Wellcome Trust (Epidemic Preparedness Coronavirus research programme 221303/Z/20/Z: CABP). DTRA (HDTRA1-18-1-0051: JWR). ERC Starting Grant (757688: CJVA, KEA, 757699: JCE, RMGJH, 757699: MQ). This project has received funding from the European Union Horizon 2020 research and innovation programme - project EpiPose (101003688: WJE, YL). This research was partly funded by the Global Challenges Research Fund (GCRF) project RECAP managed through RCUK and ESRC (ES/P010873/1: AG, CIJ, TJ). Nakajima Foundation (AE). This research was partly funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care (16/137/109: CD, FYS, YL, 16/137/109 & 16/136/46: BJQ, Health Protection Research Unit for Modelling Methodology HPRU-2012-10096: TJ, PR-OD-1017-20002: AR). Royal Society (Dorothy Hodgkin Fellowship: RL). UK DHSC/UK Aid/NIHR (ITCRZ 03010: HPG). UK MRC (LID DTP MR/N013638/1: GRGL, QJL, MR/P014658/1: GMK). Authors of this research receive funding from UK Public Health Rapid Support Team funded by the United Kingdom Department of Health and Social Care (TJ). Wellcome Trust (206250/Z/17/Z: AJK, TWR, 206471/Z/17/Z: OJB, 208812/Z/17/Z: SC, SFlasche, 210758/Z/18/Z: JDM, JH, NIB, SA, SFunk, SRM). No funding (AKD, AMF, DCT, SH).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The contact survey data collection was approved by national institutional review boards. As no identifying information was provided, institutional review was not required for reanalysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study can be downloaded from the cited references. The codes used to generate these analyses and the updated synthetic matrices are available at https://github.com/kieshaprem/synthetic-contact-matrices. https://github.com/kieshaprem/synthetic-contact-matrices ER -